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Association of renal injury with nitric oxide deficiency in aged pertensive patients progressing to end-stage renal disease
SHR: Prevention by hypertension control with AT1 blockade. (ESRD) [1, 2]. In fact, hypertension is the second most
Background. Aged spontaneously hypertensive rats (SHR) common cause of chronic renal failure in the developeddevelop end-stage renal disease resembling that of uncon-
world and represents the primary risk factor for progres-trolled essential hypertension in humans. Nitric oxide (NO)
sion of renal disease [3, 4]. The spontaneously hyperten-and angiotensin II (Ang II) play an important role in the reg-
ulation of blood pressure and the growth of vascular smooth sive rats (SHR) have been an excellent animal model
muscle and renal mesangial cells. The relationship between for genetic hypertension that bears a resemblance to that
renal NO system, Ang II activity and renal injury in aged SHR of essential hypertension in humans [5]. The adult SHRis not fully understood.
develop severe hypertension with relatively normal car-Methods. The 8-week-old SHR were randomized into losar-
tan-treated (30 mg/kg/day for 55 weeks) and vehicle treated diac and renal functions. However, with aging SHR exhibit
groups. The age-matched Wistar-Kyoto rats (WKY) served as marked proteinuria and severe glomerulosclerosis [5–8].
controls. Renal histology and tissue expressions of endothelial Inhibition of angiotensin converting enzyme (ACEi) has
and inducible NO synthases (eNOS and iNOS) and nitrotyro-
been shown to limit glomerular injury in aged SHR,sine were examined at 63-weeks of age.
indicating the crucial role of renin-angiotensin system inResults. Compared to the WKY group, untreated SHR
showed severe hypertension, proteinuria, renal insufficiency, this model [8].
a twofold decrease in renal tissue eNOS and iNOS expressions Nitric oxide (NO) plays a major role in regulation of
and massive nitrotyrosine accumulation. This was associated vascular resistance and arterial blood pressure [9]. Inwith severe glomerulosclerosis, tubular atrophy and interstitial
addition, NO can inhibit the growth of vascular smoothfibrosis. Losartan therapy normalized blood pressure, prevented
muscle, mesangial cells and reduce production of extra-proteinuria and renal insufficiency, abrogated the fall in renal
eNOS and iNOS protein contents, mitigated renal nitrotyrosine cellular matrix [10, 11]. NO is synthesized from l-argi-
accumulation, and prevented the histological abnormalities nine by a family of enzymes known as NO synthase (NOS),
found in the untreated SHR. which include constitutive and inducible isoforms [9].Conclusions. Aged SHR exhibit severe renal lesions with
We [12] and others [13–17] have recently demonstratedacquired NO deficiency that are prevented by hypertension
an up-regulated NOS expression in young SHR both be-control with AT1 blockade. These findings point to the possible
role of NO deficiency in the pathogenesis of renal lesions in fore and after the onset of hypertension. However, avail-
aged SHR. able data on the l-arginine:NO system in the aged SHR
are very scant. In their previous study, Cuevas et al showed
a dramatic decline in the percentage of endothelial cells
Effective antihypertensive therapy has dramatically with detectable endothelial NOS (eNOS) on histochemi-
reduced the morbidity and mortality from cerebrovascu- cal examination of thoracic aorta in aged SHR [18]. Re-
lar incidents and ischemic heart disease. However, there cently, Chou et al demonstrated a decreased eNOS ac-
has been an unrelenting increase in the numbers of hy- companied by increased inducible NOS (iNOS) protein
expression in aorta of aged SHR [19]. However, the NO
system in renal tissue was not investigated in those studies.
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reactive and cytotoxic byproducts, such as peroxynitrite, specimen were examined using the sections stained with
PAS. Each glomerulus was graded as follows: grade 0 which can, in turn, react with free tyrosine and tyrosine
residues in protein molecules to produce nitrotyrosine normal glomerulus by light microscopy; grade 1 
involvement of up to one third of the glomerular area;[23]. In fact, nitrotyrosine accumulation in the thoracic
aorta has been shown in adult stoke-prone SHR [22]. grade 2 involvement of one to two thirds of the glomer-
ulus; and grade 3  two thirds to global sclerosis. EachHowever, information on aged SHR is lacking.
The present study was undertaken to investigate the score was then calculated according to the formula: Glo-
merular Injury Score  [(1  number of grade 1 glo-relationship between renal NOS and nitrotyrosine ex-
pressions and renal injury in aged SHR. In addition, it meruli)  (2  number of grade 2 glomeruli)  (3 
number of grade 3 glomeruli)] 100/(number of glomer-is known that both angiotensin II (Ang II) and NO are
synthesized and released in the kidney, and the antago- uli observed).
To evaluate the arteriolar injury score, 40 to 50 affer-nistic interaction of these two agents is an important
determinant of histopathological events in the kidney ent arterioles were examined from each specimen and
were graded as follows: grade 0  no arteriolar changes;[5, 24]. Therefore, we sought to investigate the effects
of long-term Ang II subtype 1 (AT1) receptor blockade grade 1  hyalinosis of the arteriolar wall up to 50% of
its circumference; grade 2  50 to 100% hyalinosis ofwith losartan, on renal histology and the NO system.
the wall circumference but without luminal narrowing;
and grade 3 complete hyalinosis of the wall with lumi-
METHODS
nal encroachment. Each score was then calculated ac-
Animal models cording to the formula: Arteriolar Injury Score  [(1 
number of grade 1 arterioles)  (2  number of grade 2Eight-week-old male SHR and Wistar-Kyoto rats
(WKY) were purchased from Harlan Sprague, Inc. (Indi- arterioles)  (3  number of grade 3 arterioles)]  100/
(number of afferent arterioles observed). The total injuryanapolis, IN, USA). The animals were housed in a cli-
mate-controlled and light-regulated room (12 hour light/ score was then calculated by adding the glomerular and
arteriolar injury scores of each rat.12 hour dark cycle). Food and water were available ad
libitum. The SHR were randomly divided into losartan
Measurements of plasma and urine NO2 /NO3 (NOx)treated (30 mg/kg/day) and vehicle treated groups. Age-
matched WKY rats served as the controls. The selection The amount of total nitrate and nitrite in the test
samples was determined as described earlier [26–29] us-of losartan dosage was based on earlier studies demon-
strating optimal blood pressure control with the chosen ing the purge system of a Sievers Instruments Inc., (Boul-
der, CO, USA).dosage in this model [25]. The animals were carefully main-
tained and monitored for 55 weeks. Tail arterial blood
Immunoperoxidase studiespressure was determined using a tail sphygmomanome-
ter (Harvard Apparatus, Natick, MA, USA) every month. Immunohistochemical staining for eNOS, iNOS and
nitrotyrosine was performed using a standardized strep-At the conclusion of the study, animals (63-weeks-old)
were placed in metabolic cages for a 24-hour urine collec- tavidin-biotin-peroxidase method on formalin-fixed par-
affin embedded renal tissues as described earlier [27–29].tion. The urine samples were collected in sterilized con-
tainers that were chilled over ice and stored at 70C Except for the incubation with the primary antibodies, all
incubations were at room temperature and were separateduntil assayed. The animals were then sacrificed by exsan-
guination using cardiac puncture between the hours of by washes with phosphate-buffered saline (PBS). Micro-
wave heat-induced antigen retrieval in citrate buffer, pH9 am and 11 am. The plasma and kidney were harvested
immediately and appropriately stored until processed. 6.0, was required for optimal staining with all antibodies.
After deparaffinization, sections were treated with 3%
Histologic examination hydrogen peroxide to block endogenous peroxidase activ-
ity. After preincubation with 10% normal horse or swineSix animals in each group were exsanguinated for mor-
phological studies. Immediately after exsanguination, serum for 20 minutes, sections were incubated with pri-
mary antibodies overnight at 4C, followed sequentiallythe kidneys were removed and promptly sectioned and
separately post-fixed in 10% buffered formalin. The fixed with biotinylated horse anti-mouse (Vector Laboratories,
Burlingame, CA, USA) or biotinylated swine anti-rabbittissue was embedded in paraffin and sectioned. The sec-
tions were stained with Masson’s trichrome, periodic (Dako Corporation, Carpinteria, CA, USA) antibodies
for 20 minutes, and streptavidin-peroxidase complexacid-Schiff (PAS), and hematoxylin and eosin (H&E).
Glomerular and arteriolar injuries were scored semi- (Dako) for 30 minutes. The working concentrations for
the mouse anti-eNOS monoclonal antibody (Transduc-quantitatively as described previously [8]. For the eval-
uation of glomerular injury score, approximately 50 sub- tion Laboratories, Lexington, KY, USA), rabbit anti-
iNOS antibody (Transduction) and rabbit anti-nitrotyro-capsular and 50 juxtamedullary glomeruli from each
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Table 1. Blood pressure, urinary protein excretion and was then washed for 30 minutes in a shaking bath, chang-
creatinine clearance in the study groups
ing the wash buffer (buffer A without nonfat milk) every
Blood pressure Urinary protein CCr five minutes prior to one hour of incubation in buffer A
mm Hg mg/24 h mL/min plus goat anti-mouse IgG-HRP (horse radish peroxidase)
SHR 2205a 752.0a 1.70.2a at the final titer of 1:1000. Experiments were carried out
SHRL 1325 372.3 3.30.2
at room temperature. The washes were repeated beforeWKY 1303 341.8 3.50.1
the membrane was developed with a light emitting non-Data are mean  SE. N  6 in each group.
a P  0.05 vs. other groups radioactive method using ECL reagent (Amersham Inc.,
Arlington Heights, IL, USA). The membrane was then
subjected to autoluminography for one to five minutes.
The autoluminographs were scanned with a laser densi-
sine antibody (Upstate Biotechnology, Inc., Lake Placid, tometer (Model PD1211; Molecular Dynamics, Sunny-
NY, USA) were 0.1 g/mL, 0.05 g /mL and 5.9 g /mL, vale, CA, USA) to determine the relative optical densities
respectively. For negative controls a monoclonal mouse of the bands. In all instances, the membranes were stained
IgG1 (Bethyl Laboratories Inc., Montgomery, TX, USA) with Ponceau stain, which verified the uniformity of pro-
or normal rabbit serum was used at equivalent concen- tein load and transfer efficiency across the test samples.
trations. Diaminobenzidine (Sigma Chemical, St. Louis,
MO, USA) was used as the chromogen and hematoxylin Data presentation and analysis
was used for the nuclear counterstain. Data are presented as means  SE. Analysis of vari-
ance (ANOVA) was used for data analysis. P 	 0.05 wasTissue preparation and Western blot analysis
considered statistically significant.
Rats were sacrificed by decapitation, and one kidney
from each rat was immediately excised, cleaned with
RESULTSPBS, frozen in liquid nitrogen and stored at 75C. Tis-
sue was homogenized in five volumes of lysis buffer (1% General data
SDS, 1.0 mmol/L sodium vanadate, 10 mmol/L Tris-HCl, Data are shown in Table 1. The blood pressure value
pH 7.4) containing 10 mol/L pepstatin, 13 mol/L in the untreated SHR at age 63 weeks was significantly
leupeptin, and 1 mol/L phenylmethylsulfonyl fluoride higher than that found in the age-matched WKY group.
(PMSF). Homogenates were centrifuged at 12,000  g As expected, the aged untreated SHR showed a signifi-
for five minutes at 4C to remove tissue debris without cant rise in urinary protein excretion and a significant
precipitating plasma membrane fragments. Protein con- decline in creatinine clearance. Losartan therapy con-
centration was determined by using a Bio-Rad kit (Bio- trolled hypertension, prevented proteinuria and renal
Rad Laboratories, Hercules, CA, USA). insufficiency in aged SHR.
Western blot analysis was carried out to determine the
Urinary NOx excretionendothelial (eNOS) and inducible (iNOS) nitric oxide
synthase protein mass as previously described [26, 27, 29]. Figure 1 shows that the urinary excretion of NOx was
Anti-eNOS monoclonal antibody, peroxidase-conjugated significantly lower in untreated SHR than in the WKY
goat anti-mouse IgG antibody, anti-iNOS human endo- group. AT1 receptor blockade normalized the urinary
thelial positive control, and mouse macrophage posi- NOx excretion rate in aged SHR.
tive control were supplied by Transduction Laboratories.
eNOS and iNOS proteinsBriefly, kidney tissue preparations were size-fractionated
on 4 to 12% Tris-glycine gel (Novex, San Diego, CA, The untreated SHR group showed a significant decrease
USA) at 120 V for three hours. In preliminary experi- in renal tissue eNOS and iNOS protein expressions when
ments we found that the given protein concentrations compared with age-matched WKY rats (Fig. 2). Losartan
were within the linear range of detection for our Western therapy abrogated the fall in eNOS and iNOS protein
blot technique. After electrophoresis, proteins were trans- contents in SHR.
ferred onto a hybond-ECL membrane (Amersham Life
Renal morphology, glomerular and arteriolarScience Inc., Arlington Heights, IL, USA) at 400 mA
injury scoresfor two hours using the Novex transfer system. The mem-
brane was prehybridized in 10 mL of buffer A (10 The morphological appearance of glomeruli, arterioles
mmol/L Tris hydrochloride, pH 7.5, 100 mmol/L NaCl, and tubulointerstitium remained normal in the WKY group
0.1% Tween 20 and 10% nonfat milk powder) for one (Fig. 3A) compared with the untreated SHR (Fig. 3B).
hour and then hybridized for an additional one hour Kidneys in the untreated SHR disclosed segmental and
period in the same buffer containing 10 L of the given global glomerulosclerosis, and there was focal tubular at-
rophy, interstitial fibrosis and patchy lymphocytic infiltrate.anti-NOS monoclonal antibody (1:1000). The membrane
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Fig. 1. Urinary excretion of NO metabolites, nitrates and nitrites
(NOx), in Wistar-Kyoto rats (WKY), untreated spontaneously hyper-
tensive rats (SHR), and losartan-treated SHR (SHR-L). Values are
mean  SEM. N  6 in each group. *P  0.05 vs. other groups.
Some tubules were dilated with proteinaceous casts. The
small arteries showed marked intimal fibrosis and muscu-
lar hypertrophy. The afferent arterioles demonstrated hy-
alinosis with luminal encroachment. AT1 receptor block-
ade prevented these lesions in aged SHR (Fig. 3C).
The glomerular and arteriolar injury scores are shown
in Table 2. The glomerular damage of the subcapsular
region was mild and the arteriolar and glomerular changes
were more severe in the juxtamedullary area.
Fig. 2. Representative Western blot and the corresponding group data
depicting renal eNOS (A) and iNOS (B) protein abundance in Wistar-Immunohistologic studies for NOS
Kyoto rats (WKY), untreated spontaneously hypertensive rats (SHR),
Immunostaining of eNOS was similar between the rats and losartan-treated SHR (SHR-L). N  6 in each group. *P  0.05
vs. other groups.in WKY (Fig. 4A) and losartan treated SHR (Fig. 4C)
groups. There was strong positive staining of endothelial
and occasional smooth muscle cells in the small arteries
and arterioles. Many proximal tubules, collecting ducts, cle cells of small arteries and peritubular capillaries. How-
medullary thick ascending limb and vasa recta bundles ever, the amounts of iNOS signal were much less or negli-
as well as scattered glomerular cells were also positive. gible in the injured tubules and sclerotic glomeruli in the
The rats in the untreated SHR group revealed eNOS dis- untreated SHR group.
tributions similar to those in the other two groups (Fig. 4B).
Immunoperoxidase studies for nitrotyrosineHowever, there was less intensity of endothelial staining
in the small arteries and arterioles. In addition, the dam- In WKY (Fig. 5A) and losartan-treated SHR (Fig. 5C),
aged renal tubules and sclerotic glomeruli displayed moderate nitrotyrosine expression was seen in the proxi-
marked attenuation or lack of eNOS signals. Figure 4D mal and distal tubules of the renal cortex. The S3 seg-
represents a negative control for the immunohistochemi- ments of the proximal tubules and collecting ducts in
cal stains. the inner stripe of the outer medulla (ISOM) and in
Animals in all the three groups showed similar distri- the inner medulla (IM) were moderately positive for
butions and intensities for iNOS. The signals were local- nitrotyrosine. Mild-to-moderate smooth muscle staining
ized in the scattered glomerular cells, proximal tubules, in some of the arterial and arteriolar walls was observed.
In addition, there was scattered and weak staining incollecting ducts, scattered endothelial and smooth mus-
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Fig. 4. Tissue expression of endothelial nitric oxide synthase (eNOS)
in the kidneys of 63-week-old Wistar-Kyoto rats (WKY, A), untreated
spontaneously hypertensive rats (SHR, B) and losartan-treated SHR
(SHR-L, C ). (A) Note strong endothelial and weak/patchy smooth
muscle eNOS positivity in a small artery. The proximal epithelial cells
are strongly positive. Positive eNOS stain also is seen in occasional glo-
merular cells. (B) In contrast, eNOS expression of the arterial endothe-
lial cells is less intense in the SHR. Note the negligible eNOS signals
in the damaged renal tubules and sclerotic glomerulus. (C) The SHR-L
group show similar eNOS distributions and intensities when compared
with WKY group. (D) Negative control for the immunohistochemical
stains.
Fig. 5. Tissue expression of nitrotyrosine in the kidney of 63-week-old
Wistar-Kyoto rats (WKY, A), untreated spontaneously hypertensive
rats (SHR, B) and losartan-treated SHR (SHR-L, C ). (A) Focal mild-
to-moderate positivities are shown in scattered tubules. (B) Diffuse
strong positivities are seen in the cortical tubules. The glomerulus re-Fig. 3. Light microphotographs show juxtamedullary lesions in 63-week-
veals positive staining in occasional cells. (C) The SHR-L group showsold Wistar-Kyoto rats (WKY, A), untreated spontaneously hypertensive
a similar nitrotyrosine distribution and intensity when compared withrats (SHR, B) and losartan-treated SHR (SHR-L, C ). Normotensive
WKY group. (D) Negative control for the immunohistochemical stains.WKY reveal no significant pathologic findings, while the untreated
SHR demonstrate severe nephrosclerosis, focal tubular atrophy and
interstitial fibrosis with patchy lymphocytic infiltrates. An interlobular
artery discloses marked hyalinosis and narrowed lumen. The losartan
treated SHR display few pathologic findings. in virtually all of the proximal and distal tubules. The
S3 segments of the proximal tubules and the collecting
ducts in the ISOM and IM were strongly positive. Theglomerular visceral epithelial and endothelial cells. The
smooth muscle cells of the arteries and the arteriolesglomerular mesangial cells were essentially negative.
and the endothelial cells demonstrated moderate stain-In contrast, the untreated SHR (Fig. 5B) showed dif-
fuse strong nitrotyrosine expression in the renal cortex ing. The glomeruli revealed weak positive staining in scat-
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Table 2. Glomerular and arteriolar injury scores Thus, during the advanced phase of hypertension with
progressive vasculopathy, endothelial dysfunction andScores WKY SHR SHR-L
loss of renal parenchyma, NOS expression and NO pro-Glomerular injury score (GIS)
Subcapsular lesion 2.90.8 3.60.6 3.10.4 duction was diminished, leading to true NO deficiency
Juxtamedullary lesion 4.30.9 68.89.2a 6.21.6 in aged SHR. The resulting NO deficiency in turn can
Arteriolar injury score (AIS) 8.01.5 78.510.6a 7.72.0
contribute to the worsening of hypertension and associ-Total (GISAIS) 16.43.7 150.920.0a 17.22.1
ated end-organ damage, thus forming a vicious cycle.Abbreviations are: WKY, Wistar-Kyoto rats; SHR, spontaneously hyperten-
sive rats; SHR-L, SHR treated with losartan. Data are mean  SE. N  6 in The reduction in urinary NOx excretion also could be
each group. due to increased NO sequestration in aged SHR. Thisa P  0.05 vs. other groups
supposition was supported by detection of massive and
diffuse tissue accumulation of nitrotyrosine, which is the
footprint of NO/ROS interaction, in the aged SHR. In-
teraction of ROS, particularly superoxide with NO, leadstered visceral epithelial cells, mesangial cells and occa-
sional endothelial cells. Figure 5D represents the negative to production of peroxynitrite, which is a highly cytotoxic
reactive compound. In turn, peroxynitrite reacts withcontrol for immunohistochemical stains.
DNA, lipid and protein molecules. For instance, peroxy-
Correlations nitrite reacts with the tyrosine residues in various pro-
teins producing nitrotyrosine. Alternatively, ROS canTotal renal injury scores were inversely related to the
urinary NOx excretion rate (r  0.69, P  0.05). Like- initially activate tyrosine residues to produce tyrosyl rad-
icals that then are able to oxidize NO to produce nitroty-wise, renal injury scores were negatively related to renal
tissue eNOS (r0.88, P 0.05) and iNOS (r0.89, rosine. In addition, nitrotyrosine can be formed from
the interaction of tyrosine with other reactive speciesP  0.05) protein contents.
[34]. However, the contribution of the latter reactions
to total tissue nitrotyrosine abundance is limited and, as
DISCUSSION
such, nitrotyrosine abundance is largely a function of
Data on the status of the NO system in SHR are con- ROS interaction with NO [35]. Accordingly, the ob-
tradictory and very sparse in aged SHR; in young SHR, served accumulation of nitrotyrosine in the aged SHR
both increased [12–17] and decreased [30–33] l-argi- was necessarily indicative of inactivation and sequestra-
nine/NO pathway activities have been reported by dif- tion of NO by ROS. Hence, in addition to a reduced
ferent investigators. We recently demonstrated an en- NO production in aging SHR, increased ROS-mediated
hanced total body NO production and increased vascular NO inactivation further reduced the NO bioavailability.
and renal NOS protein expression in young SHR both Notably, the enhanced ROS-mediated NO inactivation
before and after the onset of hypertension [12, 21]. Based and protein nitration shown here in animals with genetic
on these observations, we believe that development of hypertension has been shown by our group to occur
hypertension is not due to a primary impairment of NO in several models of acquired hypertension, including
production in SHR. The present study shows a markedly hypertension induced by chronic lead exposure and
reduced urinary NOx excretion in aged SHR when com- chronic renal insufficiency [36, 37].
pared with age-matched WKY rats. This reduction in Recent animal studies suggest that in hypertension,
urinary NOx excretion in aged SHR may be due to de- NOS activity is linked with end-organ disease [17, 24].
pressed NO production. In this regard, there was a mark- For instance, increased NOS activity in young SHR was
edly reduced renal eNOS and iNOS protein content in accompanied by minimal glomerular and tubulointersti-
untreated aged SHR. The decline in eNOS protein corre- tial disease as well as minimal urinary protein excretion.
sponded to reduced eNOS immunoreactivity in endothe- However, the age-matched hypertensive Dahl salt-sensi-
lial cells of small arteries and damaged tubules and glo- tive rats (DSSR) exhibiting reduced renal NOS activity
meruli. The decline in iNOS protein content was largely had severe glomerular injury, marked tubulointerstitial
due to the loss of renal parenchyma in SHR. It should disease and heavy proteinuria [17, 24]. Occurrence of se-
be noted that the results of the present study do not con- vere nephropathy in the young DSSR but not the age-
tradict our earlier study in young SHR. Instead, the data matched SHR, which had hypertension of comparable
most likely represent different points in the natural severity and duration but divergent NOS activity, points
course of progressive hypertension and vasculopathy in to the possible renal protective action of NO. In our
this model. In fact, we obtained serial measurements of present study, aged SHR exhibited significant renal dam-
urinary NOx excretion and found the values to be mark- age characterized by glomerulosclerosis, focal tubular
edly increased early in the course and begin to steadily atrophy, interstitial fibrosis and marked arteriolopathy.
decline after approximately six months of age to the These morphological changes were accompanied by a
significant fall in urinary NO metabolite (that is, totallevels below that in the normal controls (data not shown).
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nitrate and nitrite) excretion, markedly depressed eNOS endothelium-dependent relaxation mediated by NO in
humans [43]. In addition, Cuevas et al have shown a dra-and iNOS protein expression, and massive nitrotyrosine
accumulation in the kidney. Thus, it appears that the matic decline in the percentage of endothelial cells with
detectable eNOS on histochemical examination of tho-compensatory up-regulation of NO system in the young
SHR retarded renal injury. However, persistent hyper- racic aorta in aged SHR [18]. In contrast, age-matched
normotensive WKY studied by these investigators showedtension eventually resulted in a fall of NO production
capacity that, coupled with ROS-mediated NO inactiva- sufficient immunostainable eNOS of thoracic aorta en-
dothelial cells. Similar results were found by Chou et altion, led to progressive nephropathy in aged SHR. Ad-
ministration of the AT1 receptor blocker losartan pre- in aged SHR [19]. However, these previous studies did
not investigate the NOS expression in the kidney. Toserved renal eNOS and iNOS protein expression, and
mitigated nitrotyrosine accumulation in aged SHR. In our knowledge, ours is the first study to demonstrate a
marked decline in renal eNOS and iNOS protein expres-addition, losartan therapy prevented renal injury in aged
SHR. It is of note that NADPH oxidase is thought to sion in aged SHR.
In conclusion, aged SHR exhibited severe renal le-be a major source of ROS in the vascular tissue [38] and
that this enzyme is up-regulated by both Ang II and sions with a marked reduction in urinary NOx excretion,
cyclical stretch [39, 40]. Consequently, the use of AT1 significant decline in renal NOS protein abundance, and
receptor antagonist most likely serves a dual function, massive nitrotyrosine accumulation when compared with
namely, a reduction in blood pressure through inhibition age-matched WKY rats. AT1 blockade prevented renal
of Ang II as well as alleviation of oxidative stress via injuries, preserved renal tissue NOS protein expressions,
reduction in superoxide production. Thus, blockade of mitigated nitrotyrosine accumulation, and normalized
Ang II action and amelioration of hypertension (hence, urinary NOx excretion in aged SHR. These findings point
cyclical stretch) by an AT1 blocker can attenuate oxida- to the possible contribution of acquired NO deficiency to
tive stress, ROS-NO interaction, and tyrosine nitration, the pathogenesis of hypertensive nephropathy with aging
as was seen in the losartan-treated aging SHR. In addi- in this model.
tion, we also clearly demonstrated a negative correlation
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